Kazuhiro Fukumura

4PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Software quality, processes and metricsSequence analysisPowder and particle technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 17, 2025
RBM17 Promotes the Chemoresistance of Oral Squamous Cancer Cells Through Checkpoint Kinase 1.

Miyuka Nakahara, Ryosuke Arai, Isao Tokuoka

|Apr 14, 2022
SPF45/RBM17-dependent splicing and multidrug resistance to cancer chemotherapy.

Kazuhiro Fukumura, Julian P Venables, Akila Mayeda

|Aug 14, 2021
SPF45/RBM17-dependent, but not U2AF-dependent, splicing in a distinct subset of human short introns.

Kazuhiro Fukumura, Rei Yoshimoto, Luca Sperotto

|Nov 25, 2020
Rbm38 Reduces the Transcription Elongation Defect of the SMEK2 Gene Caused by Splicing Deficiency.

Shintaro Muraoka, Kazuhiro Fukumura, Megumi Hayashi

Pageof 1